InvestorsHub Logo
Followers 8
Posts 585
Boards Moderated 0
Alias Born 11/03/2014

Re: xoc post# 173383

Sunday, 02/26/2017 6:17:41 PM

Sunday, February 26, 2017 6:17:41 PM

Post# of 403047
Actually, the $21B figure was only for half interest in the drug. Implied value was $42B.


Even after the past two years of deals, AbbVie's ($ABBV) decision to pay $21 billion for Pharmacyclics, bagging half interest in the blockbuster cancer drug Imbruvica, managed to get jaws to drop among even the most jaded biotech analysts.



http://www.fiercebiotech.com/biotech/surprised-stunned-and-supportive-analysts-assess-abbvie-s-21b-pharmacyclics-deal


PCYC sale was for 21 billion, not 11 billion. Does that change your numbers for CTIX?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News